Navigation Links
Seattle’s Infectious Disease Research Institute Announces Amended License Agreement With Merck
Date:8/3/2020

Seattle’s Infectious Disease Research Institute (IDRI) today announced that an agreement has been reached, to amend and restate IDRI’s license with Immune Design, a wholly owned subsidiary of Merck (known as MSD outside of the United States and Canada). Under the amendment, the parties have agreed to modify the licensed fields and indications under which Merck has the rights to use IDRI's Glycopyranosyl Lipid Adjuvant (GLA) technology (including the GLA and SLA adjuvants), in exchange for potential milestone and royalty payments. The amendment also permits IDRI to conduct research and development of GLA and SLA to treat cancer in low resource regions, itself or through collaborations and partnerships in this area in the future.

“This is an important milestone for IDRI with a premier global vaccine manufacturer,” said IDRI’s CEO Dr. Corey Casper. “This represents an incredible opportunity for our adjuvants continued availability to people around the globe.”

IDRI is committed to sharing technology to ultimately create vaccine platforms and technologies to combat the world’s most devastating infectious diseases and cancers, with a special focus on those that affect women and children. Licensing agreements such as this permit other research organizations, universities, foundations and in this case, pharmaceutical companies, to utilize IDRI’s intellectual property, adjuvants and specific processes/formulations, all with the goal of developing new solutions for treating infectious diseases and cancers.

For more information about IDRI, visit http://www.idri.org.

About IDRI
As a nonprofit global health organization, IDRI (Infectious Disease Research Institute) takes a comprehensive approach to combat infectious diseases and cancer, combining the high-quality science of a research organization with the product development capabilities of a biotech company to create vaccines and therapeutics. IDRI combines passion for improving human health with the understanding that it is not just what our scientists know about disease, but what we do to change its course that will have the greatest impact. Founded in 1993, IDRI has 55 employees headquartered in Seattle with more than 100 partners/collaborators around the world. For more information, visit http://www.idri.org.

Read the full story at https://www.prweb.com/releases/seattles_infectious_disease_research_institute_announces_amended_license_agreement_with_merck/prweb17296386.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related medicine technology :

1. PolyU develops the world’s most comprehensive automated multiplex diagnostic system for detecting infectious respiratory pathogens in a single test
2. Next generation molecular medicine: unlocking big data for precision oncology and infectious disease.
3. uBiome Appoints Dr. Sünje Pamp, PhD, Microbial Ecology and Infectious Diseases Researcher, To its Scientific Advisory Board
4. Alzheimer’s “Germ Theory” Gaining Traction, Reports Contagion, Newsmagazine on Infectious Disease
5. Spero Therapeutics Highlights Potentiator Program Data at the 27th European Congress of Clinical Microbiology and Infectious Diseases
6. The Top 250 Developers of In-Vitro Diagnostics Tests for Cancer, Cardiovascular & Infectious Diseases
7. IsoPlexis Adds Infectious Disease Pioneer Dr. David Ho to its Scientific Advisory Board
8. Profiles of the Top 200 Developers of In-Vitro Diagnostics Tests for Cancer & Infectious Diseases 2017 - Research and Markets
9. 2017 Philippines Blood Typing, Grouping and Infectious Disease NAT Market: Volume and Sales Forecasts for 40 Tests, Emerging Technologies, Competitive Strategies
10. Kymab Expands Infectious Disease Programmes
11. Global Point of Care Testing Market, by Product (Glucometers, BGE Analyzers, Pregnancy Tests, Infectious Diseases, etc.), Outlook 2022
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2020)... ... September 02, 2020 , ... ... will moderate a roundtable discussion among industry professionals about successes and challenges of ... by American Pharmaceutical Review and will take place on October 15, ...
(Date:9/1/2020)... ... September 01, 2020 , ... ... appointed to serve as Secretary to the Board of Trustees and committee chair ... High United Way is a Denver-based nonprofit organization that fights for the education, ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... If you live in New York City ... real estate part makes sense, it’s the law of supply and demand, but are plastic ... has a significant percentage of their patients that make the four-hour trip to have ...
Breaking Medicine Technology:
(Date:9/3/2020)... ... September 03, 2020 , ... ... American Foundation for Suicide Prevention’s (AFSP) annual signature event, Out of the Darkness ... of U.S. cities to raise awareness of suicide prevention. To ensure Associate safety, ...
(Date:9/3/2020)... ... 2020 , ... MemoryCare.com, a comprehensive resource for caregivers and ... in Louisville, KY. The guide identifies 17 memory care communities based on location, ... Alzheimer’s Association , 5.6 million people age 65 and older are living with ...
(Date:9/1/2020)... , ... September 01, 2020 , ... ... new practice in Glendale. While the office will be the first to ... augmentation, tummy tucks, buttock augmentation (Brazilian butt lift), as well as rhinoplasty, facial ...
(Date:9/1/2020)... , ... September 01, 2020 , ... As fall and ... the Cohn Health Institute has taken this time to expand and grow ... its 30th Anniversary, the Cohn Health Institute will be relaunching its brand new website, ...
(Date:8/31/2020)... ... August 31, 2020 , ... The Lymphoma ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... Anniversary of Blood Cancer Awareness Month (BCAM) and its international Light it ...
Breaking Medicine News(10 mins):